Showing 1 - 2 of 2
In a country with considerable amount of active CHB patients, monotherapy with a highly potent third generation drug has the most health-gain, and is cost-effective in both HBeAg-positive and negative in all stages of liver disease. </AbstractSection> Copyright The Author(s) 2012
Persistent link: https://www.econbiz.de/10010993910
It is important to identify the effects of stock prices on financial and macroeconomic variables when the development of capital markets is concerned. In this study, AB type-SVAR models are employed, whereupon impulse response functions (IRFs) and forecast error variance decompositions (FEVDs)...
Persistent link: https://www.econbiz.de/10010756253